Showing results (1-10 of 54) with videos related to
Sort By:
Pageof 6
Pharmaceuticals (Basel, Switzerland)|September 3, 2020
Characterization of Resveratrol, Oxyresveratrol, Piceatannol and Roflumilast as Modulators of Phosphodiesterase Activity. Study of Yeast LifespanAdrián Matencio, Francisco García-Carmona, José Manuel López-NicolásFood Chemistry|May 12, 2017
The inclusion complex of oxyresveratrol in modified cyclodextrins: A thermodynamic, structural, physicochemical, fluorescent and computational studyAdrián Matencio, Francisco García-Carmona, José Manuel López-NicolásFood & Function|May 5, 2016
Encapsulation of piceatannol, a naturally occurring hydroxylated analogue of resveratrol, by natural and modified cyclodextrinsAdrián Matencio, Francisco García-Carmona, José Manuel López-NicolásTalanta|October 24, 2018
An improved "ion pairing agent free" HPLC-RP method for testing cAMP Phosphodiesterase activityAdrián Matencio, Francisco García-Carmona, José Manuel López-NicolásChemistry and Physics of Lipids|March 29, 2017
Aggregation of t10,c12 conjugated linoleic Acid in presence of natural and modified cyclodextrins. A physicochemical, thermal and computational analysisAdrián Matencio, Francisco García-Carmona, José Manuel López-NicolásPharmaceuticals (Basel, Switzerland)|October 2, 2020
Cyclic Oligosaccharides as Active Drugs, an Updated ReviewAdrián Matencio, Fabrizio Caldera, Claudio Cecone, et al.Polymers|May 8, 2019
A Way to Increase the Bioaccesibility and Photostability of Roflumilast, a COPD Treatment, by Cyclodextrin MonomersAdrián Matencio, Samanta Hernández-García, Francisco García-Carmona, et al.Food & Function|December 22, 2016
An integral study of cyclodextrins as solubility enhancers of α-methylstilbene, a resveratrol analogueAdrián Matencio, Samanta Hernández-García, Francisco García-Carmona, et al.Gels (Basel, Switzerland)|April 26, 2024
Evaluation of the Swelling Properties and Sorption Capacity of Maltodextrin-Based Cross-Linked PolymersClaudio Cecone, Gjylije Hoti, Fabrizio Caldera, et al.Pharmaceutics|May 28, 2022
Developing Novel Hydroxypropyl-β-Cyclodextrin-Based Nanosponges as Carriers for Anticancer Hydrophobic Agents: Overcoming Limitations of Host-Guest Complexes in a Comparative EvaluationShohreh Peimanfard, Ali Zarrabi, Francesco Trotta, et al.Pageof 6